Skip to main content
Premium Trial:

Request an Annual Quote

Akonni Raises $935K as It Targets $20M in Private Offering

NEW YORK (GenomeWeb News) – Akonni Biosystems has raised about $935,000 of a targeted $20 million offering, the molecular diagnostics firm disclosed in a document filed with the US Securities and Exchange Commission.

The raise is in the form of equity, it said. The company said three investors participated in the round but did not identify them. It also did not provide an intended use of the proceeds and did not respond to a request for comment.

Based in Frederick, Md., Akonni develops, manufactures, and markets integrated molecular diagnostic systems. For the clinical markets, its lead platform is the Akonni TruDiagnosis system, which uses gel-drop microarrays. It also offers Akonni TruTip kits for extracting nucleic acids for the life science research market.

A year ago, the company said in an SEC filing that it was seeking to raise $8 million.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.